Plasma exchange for cold agglutinin hemolytic anemia

Area of Science:

• Hematology
• Oncology

Background:

• Chronic cold agglutinin disease (CAD) is an autoimmune hemolytic anemia often refractory to conventional treatments.
• Advanced lymphoma can complicate CAD management, necessitating alternative therapeutic strategies.

Observation:

• Two patients with advanced lymphoma and severe CAD underwent exchange plasma transfusion.
• The first patient received manual exchange, while the second underwent continuous-flow centrifugation using the Aminco Celltrifuge.

Findings:

• Both patients demonstrated a significant reduction in cold agglutinin titers post-transfusion.
• The patient treated with continuous-flow centrifugation showed improved in vitro compatibility and transfusion tolerance.
• The manual exchange patient experienced no apparent clinical benefit and ultimately died from widespread lymphoma.

Implications:

• Continuous-flow centrifugation exchange plasma transfusion is a viable therapeutic option for complex cases of cold agglutinin disease, particularly when refractory to standard therapies.
• This technique may improve patient outcomes by enhancing transfusion compatibility and tolerance in hematologic malignancies.
• Further research into optimizing continuous-flow centrifugation protocols for autoimmune hemolytic anemias is warranted.